164 related articles for article (PubMed ID: 38509247)
1. The contribution of vitamin D insufficiency to the onset of steatotic liver disease among individuals with metabolic dysfunction.
Lee SB; Jin MH; Yoon JH
Sci Rep; 2024 Mar; 14(1):6714. PubMed ID: 38509247
[TBL] [Abstract][Full Text] [Related]
2. Association between serum 25-hydroxy vitamin D concentrations and mortality among individuals with metabolic dysfunction-associated fatty liver disease: a prospective cohort study.
Zhang JJ; Yu HC; Li Y; Zhang YB; Geng TT; Lu Q; Liao YF; Guo KQ; Du L; Ruan HL; Yang K; Liu G; Pan A
Am J Clin Nutr; 2022 Nov; 116(5):1409-1417. PubMed ID: 36107812
[TBL] [Abstract][Full Text] [Related]
3. Association between serum 25-hydroxy vitamin D level and metabolic associated fatty liver disease (MAFLD)-a population-based study.
Wan B; Gao Y; Zheng Y; Chen R
Endocr J; 2021 Jun; 68(6):631-637. PubMed ID: 33658438
[TBL] [Abstract][Full Text] [Related]
4. Metabolic dysfunction associated fatty liver disease (MAFLD) and serum vitamin D concentration in South Korea.
Lee HK; Shin SR; Han AL
Asia Pac J Clin Nutr; 2022; 31(2):201-207. PubMed ID: 35766555
[TBL] [Abstract][Full Text] [Related]
5. Validation of non-invasive indicators in the screening of metabolic dysfunction-associated fatty liver disease: a cross-sectional study among Uighurs in rural Xinjiang.
Guo Y; Hu Y; Yang J; Ma R; Zhang X; Guo H; Wang X; Li Y; Peng X; Zhang S; He J; Guo S
Eur J Med Res; 2023 Dec; 28(1):555. PubMed ID: 38042816
[TBL] [Abstract][Full Text] [Related]
6. Dietary composition and its association with metabolic dysfunction-associated fatty liver disease among Chinese adults: A cross-sectional study.
Niu Z; Liu J; Peng H; Wu X; Zheng X; Yao S; Xu C
Arab J Gastroenterol; 2024 May; 25(2):205-213. PubMed ID: 38378357
[TBL] [Abstract][Full Text] [Related]
7. Effect of serum vitamin D on metabolic associated fatty liver disease: a large population-based study.
Guan Y; Xu Y; Su H; Sun X; Li Y; Wang T
Scand J Gastroenterol; 2022 Jul; 57(7):862-871. PubMed ID: 35170370
[TBL] [Abstract][Full Text] [Related]
8. Associations of serum folate and vitamin C levels with metabolic dysfunction-associated fatty liver disease in US adults: A nationwide cross-sectional study.
Jiang Y; Cao H; Chen X; Yu G; Song C; Duan H; Tian F; Wan H; Shen J
Front Public Health; 2022; 10():1022928. PubMed ID: 36388270
[TBL] [Abstract][Full Text] [Related]
9. Severity and Remission of Metabolic Dysfunction-Associated Fatty/Steatotic Liver Disease With Chronic Kidney Disease Occurrence.
Gao J; Li Y; Zhang Y; Zhan X; Tian X; Li J; Wang R; He Y; Wang A; Wu S
J Am Heart Assoc; 2024 Mar; 13(5):e032604. PubMed ID: 38390843
[TBL] [Abstract][Full Text] [Related]
10. The Association between Vitamin D Insufficiency and Nonalcoholic Fatty Liver Disease: A Population-Based Study.
Ha Y; Hwang SG; Rim KS
Nutrients; 2017 Jul; 9(8):. PubMed ID: 28749418
[TBL] [Abstract][Full Text] [Related]
11. Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Fatty Liver-Related Indices in a Japanese Population.
Moriyama K
Metab Syndr Relat Disord; 2024 Apr; 22(3):190-198. PubMed ID: 38153394
[No Abstract] [Full Text] [Related]
12. Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study.
Jung CY; Koh HB; Park KH; Joo YS; Kim HW; Ahn SH; Park JT; Kim SU
Diabetes Metab; 2022 Jul; 48(4):101344. PubMed ID: 35346856
[TBL] [Abstract][Full Text] [Related]
13. Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study.
van Kleef LA; Ayada I; Alferink LJM; Pan Q; de Knegt RJ
Hepatology; 2022 Feb; 75(2):419-429. PubMed ID: 34453359
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D Status Presents Different Relationships with Severity in Metabolic-Associated Fatty Liver Disease Patients with or without Hepatitis B Infection.
Luo L; Ye J; Shao C; Lin Y; Sun Y; Feng S; Wang W; Zhong B
Nutrients; 2022 May; 14(10):. PubMed ID: 35631255
[TBL] [Abstract][Full Text] [Related]
15. Low vitamin D levels and non-alcoholic fatty liver disease, evidence for their independent association in men in East China: a cross-sectional study (Survey on Prevalence in East China for Metabolic Diseases and Risk Factors (SPECT-China)).
Zhai HL; Wang NJ; Han B; Li Q; Chen Y; Zhu CF; Chen YC; Xia FZ; Cang Z; Zhu CX; Lu M; Lu YL
Br J Nutr; 2016 Apr; 115(8):1352-9. PubMed ID: 26888280
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update.
Barchetta I; Cimini FA; Cavallo MG
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33126575
[TBL] [Abstract][Full Text] [Related]
17. A new risk stratification strategy for fatty liver disease by incorporating MAFLD and fibrosis score in a large US population.
Zhang YC; Lyu ZY; Ma B; Li LM; Wang W; Sheng C; Dai HJ; Huang YB; Song FF; Song FJ; Chen KX
Hepatol Int; 2022 Aug; 16(4):835-845. PubMed ID: 35701716
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Risk Factors of Metabolic Dysfunction-Associated Fatty Liver Disease with Renal Insufficiency in Overweight/Obese Adults.
Shi A; Deng J; Ma J; Yang L; Tantai X; Wang Q; Chang D; Wang J; Guo X; Lu X; Shi H
Obes Facts; 2023; 16(6):548-558. PubMed ID: 37640023
[TBL] [Abstract][Full Text] [Related]
19. MAFLD and risk of CKD.
Sun DQ; Jin Y; Wang TY; Zheng KI; Rios RS; Zhang HY; Targher G; Byrne CD; Yuan WJ; Zheng MH
Metabolism; 2021 Feb; 115():154433. PubMed ID: 33212070
[TBL] [Abstract][Full Text] [Related]
20. Identifying inflammatory bowel disease patients at risk of metabolic dysfunction-associated fatty liver disease: usefulness of non-invasive steatosis predictive scores.
Capela TL; Silva VM; Freitas M; Arieira C; Gonçalves TC; de Castro FD; Magalhães J; Cotter J
BMC Gastroenterol; 2023 Dec; 23(1):437. PubMed ID: 38093213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
